Biologics
Biologics by McKesson is an independent specialty pharmacy subsidiary of McKesson Corporation dispensing oncology, rare disease, and cell and gene therapies, supported by integrated hub services for biopharma manufacturers across 30,000 provider relationships and 500 payer contracts.
- Company typePrivate
- Founded1994
- HeadquartersCary, United States
- Headcount251–500
- GTM typeB2B
- OfferingServices
What Biologics does
Biologics by McKesson is an independent specialty pharmacy subsidiary of McKesson Corporation (NYSE: MCK), headquartered in Cary, North Carolina. Founded in 1994 as the nation's first cancer-focused specialty pharmacy, the company dispenses specialty medications across three core therapy areas: oncology, rare and orphan diseases, and cell and gene therapy. It manages over 200 specialty therapies, including 130 limited distribution medications and 100+ oral therapies, supported by 30,000 active provider relationships and 500+ payer network contracts, with a reported 98% patient satisfaction rate.
The platform combines specialty pharmacy dispensing with an integrated suite of hub services, including access and reimbursement support, affordability programs, case management and adherence, non-commercial dispensing, provider engagement, biopharma reporting and insights, and technology integration. For cell and gene therapy specifically, Biologics leverages InspiroGene by McKesson, the parent company's center of excellence, to provide cold-chain infrastructure and specialized patient support. The technology stack is purpose-built for specialty prescription workflows, including prior authorizations, appeals processing, and patient adherence monitoring, and is delivered through dedicated provider and patient portals.
Biologics generates revenue through two primary streams: transaction-based specialty pharmacy dispensing (drug reimbursement and dispensing fees) and managed services hub contracts with biopharma manufacturers. Its customer base spans three primary segments: patients and families navigating complex medication journeys, healthcare providers needing specialty prescription support, and biopharma partners launching high-value specialty drugs. The company holds URAC Specialty Pharmacy Accreditation, ACHC Gold Seal of Accreditation, ACHC Oncology accreditation, and NASP corporate membership.
Biologics firmographics
Firmographics- Name
- Biologics
- Legal name
- Biologics by McKesson
- Website
- https://biologicsinc.com
- Company type
- Private
- Founded year
- 1994
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Short description
- Biologics by McKesson is an independent specialty pharmacy subsidiary of McKesson Corporation dispensing oncology, rare disease, and cell and gene therapies, supported by integrated hub services for biopharma manufacturers across 30,000 provider relationships and 500 payer contracts.
- Ownership category
- akta.pro rank
Biologics industry classification
Industry- Product category
- Specialty Pharmacy Services
- NAICS
- Ambulatory Health Care Services (621)
- SIC
- Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Biological Products, (No Disgnostic Substances) (2836)
- akta.pro primary industry
- Specialty Pharmacy & Biologics Distribution (CRAOAHAD)
- akta.pro secondary industries
- Specialty Pharma & Biologics Distribution (GDP-compliant) (HLAGAMAD), Specialty Pharmacy & Complex Therapy Management Platforms (HLACAKAG)
Keywords
Where Biologics is headquartered
LocationHeadquarters
- HQ city
- Cary
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Biologics business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Supply Chain, Operations, Infrastructure, Technology or R&D, Marketing or Sales
Revenue model
- Specialty Pharmacy Dispensing: Biologics dispenses specialty medications including exclusive and limited distribution drugs, generating revenue through pharmacy dispensing fees and drug reimbursement.
- Hub Services for Biopharma Partners: Biologics provides patient hub services including access and reimbursement support, affordability programs, case management, provider engagement, and biopharma reporting and insights. Revenue generated through contracted service agreements with biopharma manufacturers.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels4 records
Biologics product offering
Product offeringCore offering
Biologics by McKesson operates an independent specialty pharmacy that dispenses oncology, rare disease, and cell and gene therapy medications to patients while delivering integrated hub services to biopharma manufacturers. The company supports 200+ therapies including 130 limited distribution drugs and provides access/reimbursement support, affordability programs, case management, and provider engagement services.
Product overview
Biologics by McKesson is an independent specialty pharmacy operating as a platform of integrated services across three core therapy areas: Oncology, Rare & Orphan Diseases, and Cell & Gene Therapy. The platform is built around core dispensing services complemented by a suite of Hub Services modules including Access & Reimbursement, Affordability Support, Case Management & Adherence, Non-Commercial Dispensing, Provider Engagement, Biopharma Reporting & Insights, and Technology & Integration. The specialty pharmacy manages over 200 therapies including 130 limited distribution medications and 100 oral therapies including oral oncolytics. Key sub-brands include Pharmacy Elite (hub services for biopharma partners) and InspiroGene (McKesson's cell and gene therapy center of excellence that Biologics leverages for CGT support). The company also operates patient-facing services including financial assistance, patient advocacy support, and clinical adherence programs, alongside provider-facing tools including prescribing support, risk-based care programs, and specialty drug lists.
Differentiator
Problem solved
Functional benefit
Products and services
- Specialty Pharmacy Services - Oncology Personalized specialty pharmacy support for high-volume oncology therapies, including dispensing, clinical support, and access services for cancer patients and their providers.
- Specialty Pharmacy Services - Rare & Orphan Diseases Specialty pharmacy services with disease- and therapy-aligned teams trained on rare diseases, orphan therapies, and patient populations including children and teens.
- Cell & Gene Therapy Services Specialty pharmacy dispensing and patient hub services for high-risk cell and gene therapies, including cold-chain logistics and clinical support.
- Pharmacy Elite Hub Services Comprehensive hub services for biopharma partners, bundling access/reimbursement, affordability, case management, provider engagement, biopharma reporting, and technology integration.
- InspiroCare Hub Services Specialized hub services for cell and gene therapy biopharma partners, providing purpose-built patient support, commercialization, and access services.
- Specialty Drugs List Over 200 specialty therapies including 130 limited distribution medications and 100+ oral therapies covering cancer and rare/complex diseases, accessible through the provider portal.
- Patient Financial Assistance Program Financial assistance services connecting patients with grants and support programs to reduce out-of-pocket costs for specialty medications.
Quantifiable outcome
- 98% patient satisfaction rate
- +3 more outcomes
Companies that use Biologics
Customer profileNamed customers5 records
Segments4 records
Ideal customer profiles3 records
Biologics technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Biologics partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered major and core.
- Rigel PharmaceuticalsmajorBiologics by McKesson's Pharmacy Elite was awarded the hub contract by Rigel Pharmaceuticals to provide hub services for Tavalisse, Gavreto, and Rezlidhia.
- InspiroGene by McKessoncoreBiologics partners with InspiroGene by McKesson, a center of excellence for cell and gene therapy, to provide integrated pharmacy and hub services for high-risk cell and gene therapies.
- PrecigenmajorBiologics by McKesson, in partnership with InspiroGene, was selected by Precigen to support specialty pharmacy and patient hub services for the launch of a novel immunotherapy.
- Iovance BiotherapeuticsmajorBiologics by McKesson was chosen as the exclusive specialty pharmacy partner for Amtagvi (lifileucel), the first FDA-approved cell therapy for solid tumors.
- McKessoncoreBiologics is an independent specialty pharmacy and subsidiary of McKesson Corporation, leveraging McKesson's distribution network, scale, and infrastructure including cold-chain capabilities for cell and gene therapy.
Scale indicators8 records
Recent moves6 records
Expansion highlights4 records
Biologics competitors and assessment
Company assessmentBroad incumbents
- Accredo (Express Scripts): Accredo is the largest U.S. specialty pharmacy by volume, owned by Express Scripts/Cigna. It competes with Biologics across oncology, rare disease, and CGT, and benefits from captive PBM patient flow.
- Diplomat Pharmacy (Optum Specialty): Diplomat was a leading independent specialty pharmacy in oncology and rare diseases before being acquired by Optum/UnitedHealth; it now competes with Biologics as part of Optum's vertically integrated specialty platform.
- Walgreens Specialty Pharmacy: Walgreens Specialty Pharmacy is a large-scale specialty pharmacy provider within Walgreens Boots Alliance, competing in oncology and complex therapy dispensing with national retail-pharmacy reach.
- CVS Specialty: CVS Specialty is the specialty pharmacy arm of CVS Health, offering broad specialty dispensing and hub services with strong payer integration via CVS Caremark — a significant competitor in the same therapy areas as Biologics.
Direct peers
- Onco360: Onco360 is one of the largest independent oncology-focused specialty pharmacies in the U.S., competing head-to-head with Biologics for oncology dispensing contracts and limited distribution drug assignments.
- US Bioservices (AmerisourceBergen / Cencora): US Bioservices is a specialty pharmacy and hub-services provider owned by Cencora (formerly AmerisourceBergen), competing directly with Biologics in oncology, rare disease, and biopharma hub services.
- Bioplus Specialty Pharmacy: Bioplus is an independent specialty pharmacy focused on oncology, hematology, and rare diseases, offering dispensing and hub services that directly overlap with Biologics' core offerings.
- PantherRx Rare: PantherRx Rare is a specialty pharmacy exclusively focused on rare and orphan disease therapies, directly competing with Biologics' rare disease franchise and limited distribution medications.
- Amber Specialty Pharmacy: Amber Specialty Pharmacy is a Hy-Vee-owned specialty pharmacy providing oncology, rare disease, and infusion therapies with hub services, positioning it as a direct mid-market competitor to Biologics.
Emerging players
- CPS Solutions (Comprehensive Pharmacy Services): CPS operates specialty and hospital pharmacy programs including limited distribution drug services, with partial overlap to Biologics in complex therapy support and provider-facing pharmacy services.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
Biologics social profiles
Digital presenceBiologics compliance and trust
Trust signalCompliance4 records
Biologics financial estimates
Financial estimateRevenue estimate
Valuation estimate
Biologics leadership team
Management profileNumber of profiles
Profiles2 records
Biologics funding detail
Funding detailFunding overview
Funding rounds2 records
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Biologics M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Biologics
What does Biologics do?
Biologics by McKesson operates an independent specialty pharmacy that dispenses oncology, rare disease, and cell and gene therapy medications to patients while delivering integrated hub services to biopharma manufacturers. The company supports 200+ therapies including 130 limited distribution drugs and provides access/reimbursement support, affordability programs, case management, and provider engagement services.
Is Biologics a public or private company?
Biologics is a private company. It is classified as corporate owned and is currently operating.
When was Biologics founded?
Biologics was founded in 1994. It employs 251 to 500 people.
Where is Biologics based?
Biologics is headquartered in Cary, United States, in the North America region.
How does Biologics make money?
Two revenue lines are on record. Specialty Pharmacy Dispensing is the primary driver. The others are hub Services for Biopharma Partners.
Who are Biologics's main competitors?
Broad incumbents on record are Accredo (Express Scripts), Diplomat Pharmacy (Optum Specialty), Walgreens Specialty Pharmacy and CVS Specialty. Direct peers are Onco360, US Bioservices (AmerisourceBergen / Cencora), Bioplus Specialty Pharmacy, PantherRx Rare and Amber Specialty Pharmacy. CPS Solutions (Comprehensive Pharmacy Services) is listed as an emerging player.
Does Biologics have an API?
No public API is recorded for Biologics.
What industry is Biologics in?
Biologics's product category is Specialty Pharmacy Services. Its primary akta.pro industry code is CRAOAHAD, Specialty Pharmacy & Biologics Distribution, with a secondary code of HLAGAMAD, Specialty Pharma & Biologics Distribution (GDP-compliant). Its NAICS code is 621 and its SIC code is 5122.